Melissa Fore
Internal Medicine · Saint Louis, MONPI 1124380506
Payments from drug & device makers
Across 103 payments — averaging $18.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$282
- Pfizer$190
- AbbVie$187
- AstraZeneca$179
- Astellas Pharma US Inc$135
- Johnson & Johnson$123
- plus $834 from 17 others
What the payments were for
- Food & beverage$1,82495%
- Education$1065%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 13 | $282 |
| Pfizer | 14 | $190 |
| AbbVie(2 entities) | 10 | $187 |
| AstraZeneca(2 entities) | 9 | $179 |
| Astellas Pharma US Inc | 3 | $135 |
| Johnson & Johnson | 6 | $123 |
| Boehringer Ingelheim | 7 | $122 |
| Inspire Medical Systems, Inc. | 1 | $121 |
| Lilly USA, LLC | 7 | $102 |
| Amgen | 5 | $71 |
| Amarin Pharma, Inc. | 5 | $69 |
| Angiodynamics, Inc. | 1 | $45 |
| Sanofi Pasteur Inc. | 3 | $45 |
| Napo Pharmaceuticals Inc | 3 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $37 |
| GE HealthCare | 2 | $35 |
| Abbott | 2 | $29 |
| GSK | 2 | $27 |
| Sanofi-aventis U.S. LLC | 2 | $26 |
| Genentech USA, Inc. | 1 | $19 |
| Grifols USA, LLC | 1 | $16 |
| Circassia Inc. | 1 | $16 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,930 in reported general payments places this provider in the 80th percentile of 2,097 internal medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Escitalopram Oxalate | 13 | $111 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Saint Louis
- Michael ReschakSaint Louis$3.1M
- David PrelutskySaint Louis$575K
- Danish JabbarSaint Louis$510K
- Hany SalamaSaint Louis$279K
- Lauren LevineSaint Louis$264K
- Brij VaidSaint Louis$213K
- Vinay KamatSaint Louis$191K
- Tracy NorfleetSaint Louis$132K
- Paul OlivoSaint Louis$98K
- Priyanka RavalSaint Louis$95K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.